MDT Jan 2026 80.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:24PM EDT. Market open.
Loading interactive chart…
- Zacks
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.
- Simply Wall St.
We Wouldn't Be Too Quick To Buy Medtronic plc (NYSE:MDT) Before It Goes Ex-Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- PR Newswire
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of the MiniMed™ 780G system. New data shows how the system addresses hyperglycemia and nighttime burden, adding to the established body of evidence that demonstrates the system's ability to tackle unique and burdensome challenges of diabetes, such as managing highs and meal-time manage
© 2024 Yahoo. All rights reserved.